This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development. The company has a collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark.
The current price of 8GN.F is €1.20 EUR — it has decreased by -11.11% in the past 24 hours. Watch Cessatech A/S stock price performance more closely on the chart.
What is Cessatech A/S stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Cessatech A/S stocks are traded under the ticker 8GN.F.
Is Cessatech A/S stock price growing?▼
8GN.F stock has risen by +6.19% compared to the previous week, the month change is a -40% fall, over the last year Cessatech A/S has showed a -12.28% decrease.
What is Cessatech A/S market cap?▼
Today Cessatech A/S has the market capitalization of 22.29M
What is Cessatech A/S revenue for the last year?▼
Cessatech A/S revenue for the last year amounts to 765,393.23 EUR.
What is Cessatech A/S net income for the last year?▼
8GN.F net income for the last year is -1.46M EUR.
How many employees does Cessatech A/S have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is Cessatech A/S located?▼
Cessatech A/S operates in the Health & Wellness sector.
When did Cessatech A/S complete a stock split?▼
Cessatech A/S has not had any recent stock splits.
Where is Cessatech A/S headquartered?▼
Cessatech A/S is headquartered in Copenhagen, Denmark.